Skip to main content
. 2021 Dec 27;10(1):53. doi: 10.3390/biomedicines10010053

Table 4.

Overview of effects of ghrelin in experimental epilepsy models. i.c.v.: intracerebroventricular; i.h.: intrahippocampal; IHKA: intrahippocampal kainic acid; i.p.: intraperitoneal; KA: kainic acid; min: minute; pen: penicillin; pilo: pilocarpine; PTZ: pentylenetetrazole; Ref: reference.

Dose Administration
Regimen
Anticonvulsant Animal Model Ref
0.02–0.08 mg/kg i.p.
30 min prior to PTZ
yes PTZ i.p. rat model [105,117]
0.08 mg/kg i.p.
30 min prior to PTZ
no PTZ i.p. rat model [118]
0.3 nmol/µL i.h. infusion 1 x
30 min prior to PTZ
or 10 days
yes PTZ i.p. rat model [106,107]
0.08 mg/kg i.c.v.
30 min prior to PTZ
yes PTZ i.p. rat model
(female rats)
[108]
0.5, 1 and 2 µg i.c.v.
30 min after pen
yes Intracortical
penicillin rat model
[113,119]
0.08 mg/kg i.p., immediate
assessment
no WAG/Rij rat model [114]
0.01–10 µM i.h. infusion, 120 min prior to pilo yes Pilocarpine i.h.
infusion rat model
[116]
1.5 mg/kg i.p.
10 min prior to pilo
no Pilocarpine i.p.
rat model
[31,115]
1.5 mg/kg i.p.
10 min prior to KA
no KA i.p.
rat model
[115]
0.08 mg/kg i.p. 30 min prior to KA, and 24 h after KA yes KA i.p.
mouse model
[29]
1.8 mg/kg i.p.
30 min prior to pilo
yes Pilocarpine tail infusion mouse model [116]